(Q50719192)

18 March 2018

title

Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. (English)

1 reference

18 March 2018

author name string

Strehler E

1

1 reference

18 March 2018

Abt M

2

1 reference

18 March 2018

El-Danasouri I

3

1 reference

18 March 2018

De Santo M

4

1 reference

18 March 2018

Sterzik K

5

1 reference

18 March 2018

language of work or name

English

0 references

publication date

1 February 2001

1 reference

18 March 2018

published in

Fertility and Sterility

1 reference

18 March 2018

volume

75

1 reference

18 March 2018

issue

2

1 reference

18 March 2018

page(s)

332-336

1 reference

18 March 2018

Reduced in-vitro fertilization of human oocytes from patients with raised basal luteinizing hormone levels during the follicular phase

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

The role of luteinizing hormone in folliculogenesis and ovulation induction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

The effect of human menopausal gonadotrophin and highly purified, urine-derived follicle stimulating hormone on the outcome of in-vitro fertilization in down-regulated normogonadotrophic women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

Simplification of IVF: minimal monitoring and the use of subcutaneous highly purified FSH administration for ovulation induction.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

Aggressive sperm immobilization prior to intracytoplasmic sperm injection with immature spermatozoa improves fertilization and pregnancy rates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

An 18-month survey of infertility treatment by in vitro fertilization, gamete and zygote intrafallopian transfer, and replacement of frozen-thawed embryos

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

A prospective randomized clinical trial comparing recombinant follicle stimulating hormone (Puregon) and human menopausal gonadotrophins (Humegon) in non-down-regulated in-vitro fertilization patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2800%2901696-4

10.1016/S0015-0282(00)01696-4

7 January 2021

Identifiers

DOI

1 reference

18 March 2018

1 reference

18 March 2018